The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Nine states have been identified as being affected by the chocolate recall, but the products were available online so others ...
The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...
A major chocolate recall has been upgraded to the highest possible risk level.
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...